Humoral Immunity: From Regulation to Dysregulation
Humoral Immunity: From Regulation to Dysregulation
批准号:
10469165
负责人:
Thale Cross Jarvis
金额:
$0.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-03-21 至 2023-02-28
关键词:
AddressAffinityAllergicAllergic DiseaseAntibodiesAntibody ResponseAntigensAreaAutoantigensAutoimmune DiseasesAutoimmunityAutomobile DrivingB-LymphocytesCellsChronicCollaborationsCommunitiesComplexDevelopmentDiagnosticEducational workshopFeedbackFosteringFutureGenerationsGenetic ScreeningGenomicsGermanyGoalsHeartHumoral ImmunitiesImmuneImmune System DiseasesImmune responseInfectionInflammatoryInvestigationKnowledgeLeadLearningLigandsMemory B-LymphocyteMentorsMethodologyMethodsOutcomeParticipantPathologicPathologyPathway interactionsPlayProcessReactionRegulationResearchResearch PersonnelScientistStructure of germinal center of lymph nodeT-LymphocyteTimeTissuesVaccine DesignVaccinesWorkacute infectionadaptive immune responsecareercareer developmentchronic infectionclinical practicecommensal microbesdesignimaging geneticsinnovationinterestknowledge basenovelpathogenplasma cell differentiationpostersreceptorresponsesecondary lymphoid organsymposiumtoolvaccine response
中文摘要
摘要
请求支持一个题为“体液免疫:从调节到免疫”的基石研讨会。
失调,由维克托L. J. Tybulewicz、Kai-Michael Toellner、Julie Zikherman和Pamela博士组织
施瓦茨伯格会议将于2022年4月3日至6日在德国的汉诺威举行。
体液免疫是适应性免疫反应的核心。Germinal中心反应协调了
关键的B细胞-T细胞协作,导致产生B细胞记忆和长寿的亲和力成熟
保护性抗体这种关键的免疫反应已经得到了广泛的研究,因此,
对配体、受体和细胞内途径的理解越来越精细,
参与这个过程。然而,这一非凡过程的许多方面,正如它在感染中所发挥的作用,
疫苗反应和慢性免疫性疾病仍然未知。例如,没有明确的
了解B细胞如何随着时间的推移整合复杂的抗原和共刺激输入,
细胞命运决定,包括生殖中心以及记忆B细胞的克隆选择过程
和长寿的浆细胞分化。此外,没有充分认识到“非-
典型的B细胞对各种慢性和急性感染的反应,特别是那些发生在组织中的感染,而
而不是次级淋巴器官。最后,关于正常和不正常,还有许多未解之谜
B细胞对肠道植物群、过敏性抗原和自身抗原的应答,对于解决以下问题至关重要:
研究人员希望了解在炎症、过敏和免疫反应中失调的B细胞免疫反应。
自身免疫性疾病因此,这次会议汇集了专注于B细胞和
Tfh细胞对体液免疫的贡献,以分享专注于解决这一问题的创新研究
广泛的问题。本次会议的目标是确定未来调查的领域,
合作,并共同产生设计更好的疫苗所需的知识库,
治疗免疫失调疾病的精确策略。
英文摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled Humoral Immunity: From Regulation to
Dysregulation, organized by Drs. Victor L.J. Tybulewicz, Kai-Michael Toellner, Julie Zikherman and Pamela
Schwartzberg. The conference will be held in Hannover, Germany from April 3-6, 2022.
Humoral immunity is at the heart of the adaptive immune response. The germinal center reaction orchestrates
critical B cell-T cell collaboration, leading to the generation of B cell memory and long-lived affinity-matured
protective antibodies. This key immune response has been extensively studied, and, as a result, there has
been an increasingly refined understanding of the ligands, receptors, and intra-cellular pathways that are
involved in this process. However, many aspects of this remarkable process, as it plays out in infections,
vaccine responses, and chronic immunological diseases, remain unknown. For instance, there is no clear
understanding on how B cells integrate complex antigenic and co-stimulatory inputs over time to make critical
cell fate decisions, including the process of clonal selection in the germinal center as well as memory B cell
and long-lived plasma cell differentiation. Additionally, there is not a full appreciation for the spectrum of ‘non-
canonical’ B cell responses to various chronic and acute infections, especially those occurring in tissues rather
than secondary lymphoid organs. And finally, many unanswered questions remain about normal and abnormal
B cell responses to commensal flora, allergic antigens, and self-antigens that are essential to address if
researchers hope to understand dysregulated B cell immune responses in inflammatory, allergic, and
autoimmune diseases. Therefore, this conference brings together scientists focused on both the B cell and the
Tfh cell contributions to humoral immunity in order to share innovative research focused on addressing this
broad set of questions. It is a goal of this conference to identify areas of future investigation, foster
collaboration, and collectively generate the knowledge base required to design better vaccines and more
precise strategies to treat diseases of immune dysregulation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bioenergetics in Health and Diseases
-
批准号:10609120
-
项目类别:
-
资助金额:$1.74万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Autophagy and Neurodegeneration: Mechanisms to Therapies
-
批准号:10608666
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Adipose Tissue: Energizing Good Fat
-
批准号:10609127
-
项目类别:
-
资助金额:$2.02万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Cancer Neoantigens, Vaccines and Viruses
-
批准号:10233861
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Small Regulatory RNAs: From Bench to Bedside
-
批准号:10462420
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Engineering Multi-Cellular Living Systems
-
批准号:10462913
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Malaria: Confronting Challenges From Drug Discovery to Treatment
-
批准号:10468493
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Gut-Brain Axis
-
批准号:10467819
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
The Human Microbiome: Ecology and Evolution
-
批准号:10391370
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Modern Phenotypic Drug Discovery: From Chemical Biology to Therapeutics
-
批准号:10468419
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Drug Delivery to the Brain: Challenges and Progress
-
批准号:10540503
-
项目类别:
-
资助金额:$1.77万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Neurocircuitry of Social Behavior
-
批准号:10540465
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Progress in Vaccine Development for Infectious Diseases
-
批准号:10467880
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Resolution of Inflammation
-
批准号:10469175
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Organoids as Tools for Fundamental Discovery and Translation
-
批准号:10469084
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Tissue Fibrosis and Repair: Mechanisms, Human Disease and Therapies
-
批准号:10462412
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Novel Approaches Against Emerging Antimicrobial Resistance
-
批准号:10391767
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Precision Genome Engineering
-
批准号:10391367
-
项目类别:
-
资助金额:$2.22万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Neuronal Control of Appetite
-
批准号:10468571
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Innate Immunity: Complement and Beyond
-
批准号:10464340
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
海外基金